Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Shares Outstanding (Weighted Average): 2010-2024

Historic Shares Outstanding (Weighted Average) for EyePoint Pharmaceuticals (EYPT) over the last 15 years, with Dec 2024 value amounting to $68.3 million.

  • EyePoint Pharmaceuticals' Shares Outstanding (Weighted Average) rose 13.98% to $10.8 million in Q4 2019 from the same period last year, while for Sep 2018 it was $7.5 million, marking a year-over-year increase of 89.25%. This contributed to the annual value of $68.3 million for FY2024, which is 93.29% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Shares Outstanding (Weighted Average) of $68.3 million as of FY2024, which was up 93.29% from $35.3 million recorded in FY2023.
  • In the past 5 years, EyePoint Pharmaceuticals' Shares Outstanding (Weighted Average) ranged from a high of $68.3 million in FY2024 and a low of $14.4 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $35.3 million (2023), whereas its average is $45.9 million.
  • Data for EyePoint Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY soared of 100.48% (in 2021) over the last 5 years.
  • Over the past 5 years, EyePoint Pharmaceuticals' Shares Outstanding (Weighted Average) (Yearly) stood at $14.4 million in 2020, then skyrocketed by 100.48% to $28.8 million in 2021, then grew by 18.46% to $34.1 million in 2022, then grew by 3.60% to $35.3 million in 2023, then soared by 93.29% to $68.3 million in 2024.